Medical Voice 2nd November 2019 |
News and Updates
eMediNexus Coverage from: 
Medical Voice 2nd November 2019

5 Read Comments                

EVALI UpdateE-cigarette, or vaping, product use associated lung injury (EVALI) is an acute or subacute respiratory illness that can be severe    and life-threatening.Vaping is the process of inhaling an aerosol created by heating a substance such as nicotine or tetrahydrocannabinol (THC) with a battery-operated electronic device such as an electronic cigarette (e-cigarette).More than 1400 cases have been reported; approximately 70 percent have been male, and 80 percent are under 35 years old  (range 13 to 75 years).EVALI was initially recognized in the summer of 2019.Approximately 30% of patients have underlying asthmaThe exact pathogenesis of EVALI is unknown.EVALI suggests acute lung injury, possibly reflecting a spectrum of disease processes, rather than a single process. No     evidence of an infectious etiology has been identified.The key risk fact...
To Read or comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now